Abstract
The Medical Imaging Bundle includes the following reports:
- Mammography World Markets.
- Medical Imaging Markets.
- Nuclear Cardiology Markets.
- Picture Archiving and Communications Systems (PACS).
- Positron Emission Tomography (PET) Markets.
- Ultrasound Markets.
Mammography World Markets
The women' s mammography segment is poised for a major new phase of growth
fueled by the availability of new technology coming out of the computer and
digital areas and the higher interest of individual patients and general
healthcare consumers to take charge of their own health status. Continuous
improvements in technology are resulting in a growing number of new imaging
diagnostic tests that combine high levels of accuracy with rapid, easy-to-use
product formats. Digital mammography is driving more screening programs. The
emphasis in this TriMark Publications report is on those companies and
products that are actively developing and marketing clinical laboratory
instrumentation and reagents and supplies for performing diagnostic tests on
conditions specifically related to women' s health. This study concentrates on
the mammography market segment in large worldwide markets such as the U.S.,
Japan and Europe. Certain areas that are not covered include what is generally
characterized as digital imaging techniques instruments and reagents, PACS or
other data storage methods, or other medical imaging technologies, although
many of the instruments, reagents and techniques in the mammography market
segment are intimately associated with these broader areas. Specialty areas in
medical imaging are touched upon, since these segments are frequently a part
of the overall analytical focus of companies marketing general mammography
equipment. However, no effort is made to quantify the size of this broader
market.
Medical Imaging Markets
There will be a steady increase in demand for medical imaging services, along
with pressures to improve the quality of healthcare delivered in the home and
to lower its cost. The medical imaging segments are poised for a major new
phase of growth fueled by the availability of new technology coming out of the
computer and digital information technology segment, and the higher interest
of individual older baby boom patients and general healthcare consumers to
monitor health status. Continuous improvements in technology are resulting in
a growing number of new imaging tests that combine high levels of accuracy
with rapid, easy-to-use product formats. Digital mammography is driving more
screening programs. The purpose of this TriMark Publications report is to
describe the specific market segment of the diagnostics market sector called
medical imaging. This sector includes all of the generally-accepted imaging
activities that are currently used today, including X-ray and radiography,
mammography, magnetic resonance imaging (MRI), ultrasound, gamma camera
market, computed tomography (CT) scans and positron emission tomography (PET)
scans. It examines these clinical measurement devices and their reagents and
supplies as used in hospitals, clinics and doctor' s offices. It also includes
associated market segments like picture archiving and communications system
(PACS) markets, cardiology imaging markets, three-dimensional (3D) imaging
markets and other emerging technologies.
Nuclear Cardiology Markets
The purpose of this TriMark Publications report is to analyze and describe the
nuclear cardiology market segments in the U.S. and worldwide. It examines the
measurement devices that are utilized by physicians to diagnose and monitor
heart diseases. This study also discusses key products in nuclear cardiology
and examines the trends that are stimulating this market. It includes a survey
of all major companies actively engaged in marketing, manufacturing or
developing nuclear cardiological instrumentation, with each company discussed
in depth. The main objectives of this analysis are to: 1) identify viable
technology drivers through a comprehensive look at platform technologies for
nuclear cardiology testing; 2) obtain a complete understanding of the
individual nuclear cardiology testing platforms from their basic principles to
their clinical applications; 3) discover feasible market opportunities by
identifying high-growth applications in different clinical diagnostic areas;
4) focus on global industry developments through an in-depth analysis of the
major world markets for nuclear cardiology technology, including growth
forecasts; and 5) present market figures related to the current value of
nuclear cardiology, market projections, market share, key players, and sector
growth rates.
Picture Archiving and Communications Systems (PACS)
During the past 35 years, ultrasound and nuclear medicine were introduced into
clinical medicine, computed tomography (CT) revolutionized diagnostic
procedures and magnetic resonance imaging (MRI) emerged, bringing new
diagnostic information at the cellular level. X-ray morphed from analog films
to digital, and virtually all medical images became "soft" files on the
electronic networks. As imaging departments in healthcare facilities have
migrated from film to digital, the display and storage systems have had to
migrate too. These new digital imaging storage and display systems are called
picture archiving and communication systems (PACS). Most PACSs handle images
from various medical imaging instruments, including ultrasound, MRI, positron
emission tomography (PET), CT, endoscopy, mammograms, etc. The focus of this
TriMark Publications report is to analyze and describe the PACS market
segments. PACS market penetration in the U.S. healthcare space has been
significant, at almost 90%. A PACS network typically consists of a central
server that stores a database containing the images connected to one or more
clients via a local area network (LAN) or a wide area network (WAN) that
provides or utilizes the images. More and more PACS utilize Internet-based
technologies as their means of communication. This allows remote viewing and
diagnosis with implications for both civilian and military healthcare
facilities. Since radiology departments dominate the production of images,
interconnections with radiology information systems (RIS) are also looked at
in this study.
Positron Emission Tomography (PET) Markets
The medical imaging segments are poised for a major new phase of growth fueled
by the availability of new technology coming out of the computer and digital
information technology segment. Continuous improvements in technology are
resulting in a growing number of new imaging tests that combine high levels of
accuracy with rapid, easy-to-use product formats. Part of that medical imaging
improvement is coming from positron emission tomography (PET). PET is a
scanning technique used in combination with small amounts of radio-labeled
compounds to visualize the anatomy and function of the brain. The purpose of
this TriMark Publications report is to describe the specific market segment of
the diagnostics medical imaging market called PET scanning. This sector
includes all of the generally accepted imaging activities that are currently
used in PET, including equipment for PET, PET/CT, SPECT and the use of
radiopharmaceuticals for imaging. It examines these clinical measurement
devices and their reagents and supplies as used in hospitals and clinics. It
also reviews associated clinical market segments in which PET scanning has
taken a prominent role including cancer treatment, cardiology and neurology
imaging markets.
Ultrasound Markets
During the past 35 years, ultrasound and nuclear medicine were introduced into
clinical medicine, computed tomography (CT) revolutionized diagnostic
procedures and magnetic resonance imaging (MRI) emerged, bringing new
diagnostic information at the cellular level. X-ray morphed from analog films
to digital, and virtually all medical images became "soft" files on the
electronic superhighway. This TriMark Publications report describes the
increasingly diversified market segment of the diagnostics market sector
called ultrasonography or, more commonly, ultrasound. This sector currently
includes prenatal ultrasonography, cardiac and cardiology-imaging ultrasound,
and increasingly portable or handheld ultrasound, which some believe may
partly to fully replace the ubiquitous use of stethoscopes over time. Emerging
market segments such as three-dimensional (3D) and now four-dimensional (4D)
ultrasound are also examined.
|